Objective. Th e aim of the present investigation was to examine the eff ect of inhibition of endoplasmic reticulum stress signaling, mediated by IRE1 (inositol requiring enzyme 1), which is a central mediator of the unfolded protein response on the expression of genes encoding glucocorticoid receptor (NR3C1) and some related proteins (SGK1, SGK3, NCOA1, NCOA2, ARHGAP35, NNT) and their hypoxic regulation in U87 glioma cells for evaluation of their possible signifi cance in the control of the glioma growth.
Glucocorticoid receptor (nuclear receptor subfamily 3, group C, member 1; NR3C1) plays an important role in the regulation of numerous metabolic and proliferative processes, including tumorigenesis and metabolic diseases, such as obesity and diabetes, preferentially through interaction with specifi c response elements in the target genes (Vonlanthen et al. 2014; de Guia et al. 2015; Kim et al. 2015; Pufall 2015; Th omas et al. 2015) . Unlike other steroid hormone receptors, the glucocorticoid receptor is not considered to be an oncogene. Glucocorticoids work through NR3C1 to arrest the growth and induce apoptosis in lymphoid tissue (Pufall 2015; Huang et al. 2016) . Furthermore, transcriptional activity of NR3C1 correlates with the amount of phosphorylation at Ser-211, but its sumoylation reduces the transcription transactivation. Glucocorticoids can stimulate directly the mitochondrial transcription through glucocorticoid receptors (Minchenko and Germanyuk 1984; Minchenko 1988; Minchenko and Tronjko 1988; Psarra and Sekeris 2011) . Moreover, glucocorticoid receptors can also signal by binding to other transcription factors and modulate the transcriptional regulation of target genes (Khan et al. 2011; Li et al. 2012; Dasgupta et al. 2015) .
Th erefore, glucocorticoid receptor DNA binding factor 1 (GRF-1), also known as Rho GTPase Activating Protein 35 (ARHGAP35), is a repressor of glucocorticoid receptor transcription and represses the transcription of this receptor by binding to the cis-acting regulatory sequence (Notsuda et al. 2013; Organ et al. 2014; Zhao et al. 2014) . Nuclear receptor coactivator 2 (NCOA2), also known as a glucocorticoid receptor-interacting protein-1 (GRIP1), is a critical regulator of glucose metabolism, involved in the positive regulation of the transcriptional activity of the glucocorticoid receptor NR3C1. However, it also regulates other steroid receptors as well as thyroid, retinoid, and vitamin D receptors (Fenne et al. 2013; Liu et al. 2013; Dasgupta et al. 2015) .
Glucocorticoids are responsible for the regulation of SGK1 and SGK3 (serum/glucocorticoid regulated kinases 1 and 3), which also are induced by a very large spectrum of stimuli distinct from glucocorticoids and serum (Srivastava et al. 2014; Hausmann et al. 2015; Liu et al. 2015; Qin et al. 2015; Xiaobo et al. 2016) . Nicotinamide nucleotide transhydrogenase (NNT) is an integral protein of the inner mitochondrial membrane and functions as a proton pump across the membrane. At the same time, mutations in NNT gene cause familial glucocorticoid defi ciency (Meimaridou et al. 2012) . NNT mRNA expression is signifi cantly higher in visceral fat of obese patients and correlates with body weight and fasting plasma insulin (Heiker et al. 2013) . Moreover, in the failing heart, a partial loss of NNT activity adversely impacts NADPH-dependent enzymes and the capacity to maintain membrane potential, thus contributing to a decline in bioenergetic capacity, redox regulation and antioxidant defense (Sheeran et al. 2010) .
Regulation of diff erent metabolic processes by glucocorticoids is preferentially stress dependent, but involving the endoplasmic reticulum (ER) stress signaling has not been explored yet. Th e ER stress is mediated by three sensor and signaling pathways, but inositol requiring enzyme 1 (IRE1/ERN1) is a central mediator of the unfolded protein response and an important component of tumor growth, because its inhibition leads to a suppression of glioma growth through down-regulation of the angiogenesis and proliferation processes (Drogat et al. 2007; Auf et al. 2010 Auf et al. , 2013 . Th is stress is recognized as an important determinant of cancer, obesity, and type 2 diabetes and contributes to the expression profi le of many regulatory genes resulting in proliferation, apoptosis, angiogenesis, and insulin resistance (Minchenko et al. 2013a,b; Clarke et al. 2014; Han and Kaufman 2014; Lee and Ozcan 2014; Manie et al. 2014; Dejeans et al. 2015; Minchenko et al. 2015a) . Th e IRE1enzyme is responsible for the degradation of a specifi c subset of mRNA and alternative splicing of the XBP1 (X-box binding protein 1) transcription factor mRNA for control of the expression of unfolded protein response-specifi c genes (Acosta-Alvear et al. 2007; Aragon et al. 2009; Auf et al. 2010; Dejeans et al. 2012; Han et al. 2013; Pluquet et al. 2013; Maurel et al. 2014 Maurel et al. , 2015 .
Moreover, the ER has an essential position as a signal integrator because of the signaling pathways, elicited by ER stress sensors, have connections with the metabolic pathways and with other plasma membrane receptor signaling networks (Bravo et al. 2013; Cao and Kaufman 2013; Han et al. 2013; Clarke et al. 2014; Manie et al. 2014; Chevet et al. 2015) . Th e ER stress response-signaling pathway, mediated by IRE1, is tightly associated with the hypoxia and linked to the neovascularization, tumor growth, and cell death processes as well as suppression of insulin receptor signaling through activation of c-Jun N-terminal kinase (Langlais et al. 2011; Lenihan and Taylor 2013; Clarke et al. 2014; Minchenko et al. 2014) .
Th e main goal of this work was to study: 1) the effect of signaling enzyme IRE1 inhibition on the expression level of genes encoding the NR3C1, SGK1, SGK3, NCOA1, NCOA2, ARHGAP35, and NNT in U87 glioma cells and 2) the regulation of these gene expressions by hypoxia for evaluation of its possible signifi cance in the control of glioma growth through IRE1 mediated ER stress signaling.
Materials and Methods
Cell Lines and Culture Conditions. Th e glioma cell line U87 was obtained from ATCC (U.S.A.) and grown in high glucose (4.5 g/l) Dulbecco's modifi ed Eagle's minimum essential medium (Gibco, Invitrogen, Carlsbad, CA, U.S.A.), supplemented with glutamine (2 mM), 10% fetal bovine serum (EquitechBio, Inc., U.S.A.), penicillin (100 units/ml; Gibco) and streptomycin (0.1 mg/ml; Gibco) at 37 o C in a 5% CO 2 incubator. In this work, we used two sublines of this glioma cells. One subline was obtained by selection of stable transfected clones with over expression of vector pcDNA3.1, which was used for creation of dnI-RE1. Th is untreated subline of glioma cells (control glioma cells) was used as control 1 in the study of the eff ect of hypoxia on the expression level of glucocorticoid receptor and related genes. Second subline was obtained by selection of stable transfected clone with over expression of IRE1 dominant/negative construct (dnIRE1) and has suppressed both protein kinase and endoribonuclease activities of this signaling enzyme (Auf et al. 2010) . Th e expression level of studied genes in these cells was compared with cells, transfected by vector (control 1), but this subline was also used as control 2 for investigation the eff ect of hypoxia on gene expressions under blockade of both enzymatic activities of IRE1. Th e effi ciency of IRE1 suppression in this glioma cell subline was estimated previously (Auf et al. 2010 (Auf et al. , 2013 Minchenko et al. 2013b ) by determining the expression level of the XBP1 alternative splice variant, a key transcription factor in the IRE1 signaling, and the level of the phosphorylated isoform IRE1 using cells treated by tunicamycin (0.01 mg/ml during 2 h) for induction of ER stress. Both sublines of glioma cells, used in this study, are grown with the addition of geneticin (G418) while these cells carrying empty vector pcDNA3.1 or dnIRE1 construct.
Hypoxic condition was created in special incubator with 3% oxygen and 5% carbon dioxide levels. Th e culture plates with complete DMEM were exposed to these conditions for 16 h.
RNA isolation. Total RNA was extracted from glioma cells using the Trizol reagent (Invitrogen, Carlsbad, CA, U.S.A.). RNA pellets was washed with 75% ethanol and dissolved in nuclease-free water. For additional purifi cation RNA samples were reprecipitated with 95% ethanol and re-dissolved in nuclease-free water. RNA concentration and spectral characteristics were measured using a NanoDrop Spectrophotometer ND1000 (PEQLAB, Biotechnologie GmbH).
Reverse transcription and quantitative PCR analysis. Th e expression levels of glucocorticoid receptor (nuclear receptor subfamily 3, group C, member 1; NR3C1), serum/glucocorticoid regulated kinase 1 (SGK1), serum/glucocorticoid regulated kinase family, member 3 (SGK3),nuclear receptor corepressor 1 (NCOA1), nuclear receptor coactivator 2 (NCOA2), also known as glucocorticoid receptor-interacting protein-1, Rho GTPase Activating Protein 35 (ARH-GAP35), also known as glucocorticoid receptor DNA binding factor 1 (GRLF1), and nicotinamide nucleotide transhydrogenase (NNT) mRNAs as well as ACTB mRNA were measured in control U87 glioma cells and cells with a defi ciency of IRE1 by quantitative polymerase chain reaction in real-time using qPCR "RotorGene RG-3000" (Corbett Research, Germany) and Applied Biosystems 7500 (Applied Biosystems, U.S.A.) using SYBRGreen Mix (ABgene, Th ermo Fisher Scientifi c, Epsom, Surrey, UK). QuaniTect Reverse Transcription Kit (QIAGEN, Hilden, Germany) was used for cDNA synthesis as described previously (Minchenko et al. 2013b ). Polymerase chain reaction was performed in triplicate.
For amplifi cation of NR3C1 cDNA, we used forward (5'-tttccctcctgctccttctg-3' and reverse (5'-tcacatctcccctctcctga-3') primers. Th e nucleotide sequences of these primers correspond to sequences 382-401 and 571-552 of human NR3C1 cDNA (GenBank accession number NM_000176). Th e amplifi cation of SGK1 cDNA for real time RCR analysis was performed using two oligonucleotides primers: forward -5'-gcagaaggacaggacaaagc-3' and reverse -5'-tcggtaaactcggggtcaaa-3'. Th e nucleotide sequences of these primers correspond to sequences 1085-1104 and 1261-1242 of human SGK1 cDNA (GenBank accession number NM_005627). For amplifi cation of SGK3 cDNA we used forward (5'-attcccagctccgatgaaca-3' and reverse (5'-tcgtttagtcctgctcgtct-3') primers. Th e nucleotide sequences of these primers correspond to sequences 312-331 and 547-528 of human SGK3 cDNA (GenBank accession number NM_013257). Th e amplifi cation of ARHGAP35 cDNA for real time RCR analysis was performed using two oligonucleotides primers: forward -5'-ggcaacctgggagagtaact-3' and reverse -5'-agtctttctctgccaggtcc-3'. Th e nucleotide sequences of these primers correspond to sequences 3717-3736 and 3934-3915 of human ARHGAP35 cDNA (GenBank accession number NM_004491). For amplifi cation of NCOA1 cDNA we used two oligonucleotides primers: forward -5'-aatgatcccgcactgagaca-3' and reverse -5'-ggcttttgagttcccagtgg-3'. Th e nucleotide sequences of these primers correspond to sequences 4327-4346 and 4517-4498 of human NCOA1 cDNA (GenBank accession number NM_003743). Th e amplifi cation of NCOA2 cDNA for real time RCR analysis was performed using two oligonucleotides primers: forward -5'-gcccagagacagagggaaat-3' and reverse -5'-cgagggttgctcatagttgc-3'. Th e nucleotide sequences of these primers correspond to sequences 3868-3887 and 4031-4012 of human NCOA2 cDNA (GenBank accession number NM_006540). For amplifi cation of NNT cDNA we used two oligonucleotides primers: forward -5'-gtctcctgaaatctgcccct-3' and reverse -5'-cagcacagtgataacgacgg-3'. Th e nucleotide sequences of these primers correspond to sequences 2549-2568 and 2769-2750 of human NNT cDNA (GenBank accession number NM 012343). Th e amplifi cation of ACTB (beta-actin) cDNA for real time RCR analysis was performed using forward -5'-ggacttcgagcaagagatgg-3' and reverse -5'-agcactgtgttggcgtacag-3' primers. Th ese primers nucleotide sequences correspond to 747-766 and 980-961 of human ACTB cDNA (GenBank accession number NM_001101). Th e expression of beta-actin mRNA was used as control of analyzed RNA quantity. Th e primers were received from Sigma-Aldrich (St. Louis, MO, U.S.A.).
Quantitative PCR analysis was performed using a special computer program "Diff erential expression calculator". Th e values of NR3C1, SGK1, SGK3, NCOA1, NCOA2, ARHGAP35, and NNT gene expressions were normalized to the expression of beta-actin (ACTB) mRNA and represent as percent of control (100%). All values are expressed as mean ± SEM from triplicate measurements performed in 4 independent experiments. Statistical analysis was performed as described previously (Bochkov et al 2006) . Th e am- Figure 1 . Inhibition of IRE1 by dnIRE1 aff ects the expression level of genes encoded glucocorticoid receptor (nuclear receptor subfamily 3, group C, member 1; NR3C1), serum/glucocorticoid regulated kinase 1 (SGK1), serum/glucocorticoid regulated kinase family, member 3 (SGK3),nuclear receptor corepressor 1 (NCOA1), nuclear receptor coactivator 2 (NCOA2), also known as glucocorticoid receptor-interacting protein-1, Rho GTPase Activating Protein 35 (ARHGAP35), also known as glucocorticoid receptor DNA binding factor 1 (GRLF1), and nicotinamide nucleotide transhydrogenase (NNT) in U87 glioma cells measured by qPCR. Values of these mRNA expressions were normalized to beta-actin mRNA level and represented as percent for control (cells transfected be empty vector, 100%); n=4; *p<0.05 and **p<0.01 vs. control. plifi ed DNA fragments were also analyzed on a 2% agarose gel and that visualized by SYBR* Safe DNA Gel Stain (Life Technologies, Carlsbad, CA, U.S.A.).
Results
Inhibition ofIRE1 aff ects the expression of NR3C1, SGK1, SGK3, NCOA1, NCOA2, ARH-GAP35, and NNT genes in U87 glioma cells. To investigate a possible role of ER stress signaling, mediated by IRE1 bifunctional enzyme, in the expression level of mRNA for glucocorticoid receptor and related proteins, we studied the eff ect of IRE1 inhibition by dnIRE1 on these genes expression in U87 glioma cells. As shown in Figure 1 , the expression level of NR3C1 mRNA is signifi cantly upregulated (+50%) in U87 glioma cells by inhibition of IRE1 signaling enzyme in comparison with the control cells. Th e expression level of SGK1 mRNA in glioma cells without IRE1 signaling enzyme function is also up-regulated (+56%) in comparison with the control glioma cells. At the same time, inhibition of IRE1 by dnIRE1 strongly down-regulated the expression level of SGK3mRNA (-48%) in glioma cells in comparison with the control ones ( Figure  1 ). Furthermore, we investigated the expression of genes encoded nuclear receptor coactivator/corepressor 1 (NCOA1) and nuclear receptor coactivator 2 (NCOA2), also known as glucocorticoid receptor-interacting protein-1, as well as glucocorticoid receptor DNA binding factor 1 (GRLF1), also known as Rho GTPase Activating Protein 35 (ARHGAP35), and nicotinamide nucleotide transhydrogenase (NNT) in relation to the inhibition of IRE1 signaling enzyme function. As also shown in Figure 1 , the expression level of NCOA1 and NNT mRNAs is strongly increased (+75% and +64%, correspondingly) in glioma cells with suppressed function of IRE1 signaling enzyme. Smaller but statistically signifi cant induction was shown for ARHGAP35 (+29%) and NCOA2 genes (+19%). Th e inhibition of ER stress signaling, mediated by IRE1 enzyme, aff ected the expression level of glucocorticoid receptor and a subset of related factors in gene-specifi c manner.
Eff ect of hypoxia on the expression of NR3C1, SGK1, SGK3, NCOA1, NCOA2, ARHGAP35, and NNT genes in control glioma cells and cells without IRE1 enzyme function. Furthermore, we investigated the eff ect of hypoxia on the expression of NR3C1, SGK1, SGK3, NCOA1, NCOA2, ARHGAP35, and NNT genes in glioma cells in relation to inhibition of IRE1 signaling enzyme function. We found that expression level of NR3C1 gene is strongly upregulated by hypoxia in control glioma cells (+91% in comparison with control 1) and that inhibition of IRE1 signaling enzyme function decreases the eff ect of hypoxia on this gene expression (+64% in comparison with control 2) ( Figure 2 ). As shown in Figure  3 , hypoxia also signifi cantly enhances the expression level of SGK1 gene in the control glioma cells in comparison with the control 1 (+46%). At the same time, inhibition of IRE1 signaling enzyme strongly increases the sensitivity of SGK1 gene expression to hypoxia. Th us, in the glioma cells without IRE1 signaling enzyme function the expression level of this gene is up-regulated 2.7 times in comparison with corresponding control (control 2; Figure 3 ). Investigation of SGK3 gene expression had shown that hypoxia down-regulated its expression in both the control glioma cells and cells without IRE1 signaling enzyme function. Th us, as shown in Figure 4 , the ex- We also studied the hypoxic regulation of NCOA1 and NCOA2 genes expression in the glioma cells in relation to inhibition of IRE1 signaling enzyme function. We found that in control glioma cells, hypoxia is slightly but statistically signifi cantly up-regulated the expression level of NCOA2 gene (+15% in comparison with control 1) and does not aff ect NCOA1 the gene expression (Figures 5 and 6 ). At the same time, inhibition of IRE1 signaling enzyme function eliminates hypoxic regulation of NCOA2 gene expression and introduces sensitivity to hypoxia the expression of NCOA1 gene (-17% in comparison with control 2) in U87 glioma cells. Th us, eff ect of hypoxia on these two genes encoded nuclear receptor coactivator proteins is diff erent but mediated through IRE1 signaling pathway.
Investigation of glucocorticoid receptor DNA binding factor 1 gene expression, also known as Rho GTPase Activating Protein 35 (ARHGAP35), showed that hypoxia strongly up-regulated its expression (+75% in comparison with control 1) and that inhibition of IRE1 enzyme function by dnIRE1 eliminated its hypoxic regulation (Figure 7) . At the same time, eff ect of hypoxia on the expression level of NNT gene is signifi cantly lower. As shown in Figure 8 , hypoxia slightly but statistically signifi cantly up-regulated the expression level of this gene in control glioma cells (+16% in comparison with control 1), but inhibition of IRE1 signaling enzyme signifi cantly enhanced the hypoxic regulation of NNT gene expression (+42% in comparison with control 2).
Th us, the expression of genes, encoded by glucocorticoid receptor and a subset of related factors, is responsible for the endoplasmic reticulum stress signaling, mediated by IRE1 and hypoxia in glioma cells, in gene specifi c manner.
Discussion
In this work, we studied the expression of genes encoded glucocorticoid receptor and a subset of re- lated factors, which regulate its functional activity and expression in relation to hypoxia and inhibition of IRE1, the major signaling pathway of the unfolded protein response, in U87 glioma cells. It is important for evaluation of possible signifi cance of these genes in the control of glioma growth through ER stress signaling, mediated by IRE1 and hypoxia because stress signaling pathways is involved in numerous metabolic pathways and inhibition of the activity of IRE1 signaling enzyme in glioma cells had anti-tumor eff ects (Auf et al. 2010 (Auf et al. , 2013 Bravo et al. 2013; Minchenko et al. 2013b; Manie et al. 2014; Minchenko et al. 2014 Minchenko et al. , 2015b .
Results of this study demonstrated that inhibition of IRE1 signaling enzyme function signifi cantly increases the expression level of both NR3C1 and most related genes, indicating their participation in IRE1mediated network of the unfolded protein response. Th e changes in the glucocorticoid receptor and related factors expression in cells without IRE1 signaling enzyme function possible contribute in the suppression of glioma cell proliferation and tumor growth, because there is data that glucocorticoid receptor plays an important role in growth arrest and dexamethasonemediated killing of B lymphoma cells by induction of apoptosis (Pufall 2015; Huang et al. 2016) . It is possible that increased expression of GRF-1/ARHGAP35, NNT, NCOA1, and GRIP1/NCOA2 genes (Figure 1 ) contributes to the suppression of proliferation and glioma growth from glioma cells with IRE1 knockdown (Auf et al. 2010 (Auf et al. , 2013 Minchenko et al. 2015b ). Th us, increased expression of nicotinamide nucleotide transhydrogenase should enhance glucocorticoid receptor function because mutations in NNT cause familial glucocorticoid defi ciency (Meimaridou et al. 2012) .
However, almost all studied glucocorticoid related factors, especially serum/glucocorticoid regulated kinases and nuclear receptor coactivator/corepressor factors, are multifunctional and their biological eff ects are dependent on ER stress signaling pathways and many other factors in cell specifi c manner (Khan et al. 2011; Li et al. 2012; Fenne et al. 2013; Liu et al. 2013; Chi et al. 2015; Dasgupta et al. 2015) .Th erefore, our results conform the data indicating that NR3C1,ARHGAP35, and NCOA2 have mainly anti-proliferative functions through interaction with diff erent transcription co-regulators and signaling pathways of ER stress in cell specifi c manner (Pufall 2015; Kim et al. 2015; Huang et al. 2016) . At the same time, we have shown that SGK3 gene expression is down-regulated by inhibition of IRE1. Th ese results conform to data that inositol polyphosphate 4-phosphatase type II in melanoma functions as an oncogenic driver through activation of serum-and glucocorticoid-regulated kinase 3 (Chi et al. 2015) .
Consequently, our results demonstrate that all of the genes studied are ER stress responsive playing an essential role in the control of glucocorticoid hormone action and cell proliferation, but functional significance and molecular mechanisms of induction or suppression of these genes expression upon inhibition of IRE1 are not clear and many details remain to be elucidated. Th us, the ER has an important position as a signal integrator in both normal and malignant cells as well as in the cells upon metabolic diseases because its signaling pathways is involved in numerous metabolic pathways (Bravo et al. 2013; Cao and Kaufman 2013; Minchenko et al. 2013b; Han and Kaufman 2014; Lee and Ozcan 2014; Manie et al. 2014; Pluquet et al. 2014; Chevet et al. 2015) .
Th e investigation of hypoxic regulation of the expression of genes, encoded glucocorticoid receptor and related factors in respect to inhibition of IRE1 signaling, is very important for understanding of malignant tumor growth mechanisms, because low oxygen has essential role in the control of proliferation and tumor progression (Lenihan and Taylor 2013; Minchenko et al. 2013a Minchenko et al. , 2015a . We showed that hypoxia leads to up-regulation of the expression of NR3C1, SGK1, NCOA2, ARHGAP35, and NNT genes in control glioma cells and that inhibition of IRE1 signaling enzyme function modifi es hypoxic regulation in all studied genes. Th us, the eff ect of hypoxia on the expression level of NR3C1 gene is decreased by inhibition of IRE1 signaling enzyme in glio- ma cells, but signifi cantly increased in the expression of SGK1 and NNT genes. Moreover, IRE1 knockdown eliminates eff ect of hypoxia on the expression level of NCOA2 and ARHGAP35 genes. Th us, inhibition of IRE1 modifi es the sensitivity of some studied genes expression to hypoxia and induces negative eff ect of IRE1 inhibition on NCOA1 gene expression as well as reduces eff ect of hypoxia on the expression of NR3C1 gene in glioma cells. Th ese changes in the expression of genes encoded glucocorticoid receptor and related factors in control glioma cells upon hypoxia are similar to that in cells without IRE1 signaling enzyme function. It is not clear yet why the hypoxia up-regulates the expression of genes encoded glucocorticoid receptor and some related factors, which expression is increased by IRE1 inhibition and is correlated with anti-proliferative eff ect.
Th is study provides unique insights into the molecular mechanisms, regulating the expression of genes encoding glucocorticoid receptor and a subset of related factors and their correlation with slower cell proliferation in cells harboring dnIRE1, attesting to the fact that these genes expression is controlled by ER stress signaling and that ER stress is a necessary component of malignant tumor growth and cell survival. Moreover, the expression of some studied genes upon hypoxia is signifi cantly depended on IRE1 signaling enzyme function. However, the detailed molecular mechanisms of this regulation are complex and warrants further studies.
